Modelling of pecutaneous drug permeation and investigation of penetration enhancer effect;A bocombining double acute accentrön keresztüli hatóanyag permeáció modellezése és penetráció fokozók hatásának vizsgálata

Acta Pharmaceutica Hungarica

Volumn 82, Issue 1, 2012, Pages 15-22

  Csizmazia, Eszter ^a   Berkó, Szilvia ^a   Maroda, Mónika ^a   Szabóné Révész, Piroska ^a   Csányi, Erzsébet ^a  

^a Gyogyszertechnologiai Intezet   (Hungary)

Author keywords

Franz cell; FTIR; Human epidermis; Penetration enhance

Indexed keywords

DIETHYLENE GLYCOL MONOETHYL ETHER; SUCROSE LAURATE; DRUG DERIVATIVE; ETHYLENE GLYCOL DERIVATIVE; SUCROSE;

DRUG ACCUMULATION; DRUG ADMINISTRATION ROUTE; DRUG DIFFUSION; DRUG PENETRATION; DRUG RESEARCH; EX VIVO STUDY; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; REVIEW; SKIN ABSORPTION; ANIMAL; ARTIFICIAL SKIN; BIOLOGICAL MODEL; CHEMISTRY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG INTERACTION; INFRARED SPECTROSCOPY; INTRADERMAL DRUG ADMINISTRATION; MEMBRANE; METABOLISM; PERMEABILITY; SKIN;

ADMINISTRATION, CUTANEOUS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DIFFUSION; DRUG DELIVERY SYSTEMS; DRUG INTERACTIONS; ETHYLENE GLYCOLS; HUMANS; MEMBRANES; MODELS, BIOLOGICAL; PERMEABILITY; SKIN; SKIN ABSORPTION; SKIN, ARTIFICIAL; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SUCROSE;

EID: 84860732065     PISSN: 00016659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Cevc, G.: Expert. Opin. Inv. Drug 6, 1887-1937 (1997).
2. Schäfer-Korting, M., Mehnert, W., Korting, H-Ch.: Adv. Drug Deliver. Rev. 59, 427-443 (2007).
3. Moser, K., Kriwet, K., Naik, A., Kalia, Y.N., Guy, R.H.: Eur. J. Pharm. Biopharm. 52, 103-112 (2001).
4. Benson, H.A.E.: Curr. Drug Deliv. 2, 23-33 (2005).
5. Carsten Ehrhardt and Kwang-Jin Kim: Drug Absorption Studies In Situ, In Vitro and In Silico Models, Springer, New York
6. Ulrich F. Schaefer, Steffi Hansen, Marc Schneider, Javiana Luengo Contreras, and Claus-Michael Lehr: Models for Skin Absorption and Skin Toxicity Testing (2008).
7. Barry, B.W.: Eur. J. Pharm. Sci. 14, 101-114 (2001).
8. Thong, H.-Y., Zhai, H., Maibach, H.I.: Skin Pharmacol. Phys. 20, 272-282 (2007).
9. Mura, P., Faucci, M.T., Bramanti, G., Corti, P.: Eur. J. Pharm. Sci. 9, 365-372 (2000).
10. Mura, S., Manconi, M., Sinico, Ch., Volenti, D., Fadda, A.M.: Int. J. Pharm. 380, 72-79 (2009).
11. Ganem-Quintanar, A., Lafforgue, C., Falson-Rieg, F., Buri, P.: Int. J. Pharm. 147, 165-171 (1997).
12. D'Arpino, S., Corbrion-Archer, V., Marty, J.-P., Lantieri, L., Vincent, C.-M., Astier, A., Paul, M.: Drug Develop. Res. 58, 283-290 (2003).
13. Harrison, J.E., Watkinson, A.C., Green, D.M., Hadgraft, J., Brain, K.: Pharm. Res. 23, 542-546 (1996).
14. Csóka, G., Marton, S., Zelko, R., Otomo, N., Antal, I.: Eur. J. Pharm. Biopharm. 65, 233-237 (2007).
15. Lehmann, L., Keipert, S., Gloor, M.: Eur. J. Pharm. Biopharm. 52, 129-136 (2001).
16. Ganem-Quintanar, A., Quintanar-Guerrero, D., Falson-Rieg, F., Buri, P.: Int. J. Pharm. 173, 203-210 (1998).
17. Ayala-Bravo, H.A., Quintanar-Guerrero, D., Naik, A., Kalia, Y.N., Cornejo-Bravo, J.M., Ganem-Quintanar, A.: Pharm. Res. 20, 1267-1273 (2003).
18. Haigh, J.M., Smith, E.W.: Eur. J. Pharm. Sci. 2, 311-330 (1994).
19. Franz, T. J., Lehman, P. A., Raney, S. G., Cetera www.aapsj.org/ abstracts/AM-2008/AAPS2008003071.PDF
20. Kligman, A.E., Christophers, E.: Arch. Dermatol. 88, 702-705 (1963).
21. El Maghraby, G.M., Barry, B.W., Williams, A.C.: Eur. J. Pharm. Sci. 34, 203-222 (2008).
22. Magnusson, B.M., Walters, K.A., Roberts, M.S.: Adv. Drug Deliver. Rev. 50, 205-227 (2001).
23. Wester, R.C., Noonan, P.K., Maibach, H.I.: Arch. Dermatol. Res. 267, 229-235 (1980).
24. Reifenrath, W.G., Chellquist, E.M., Shipwash, E.A., Jederberg, W.W.: Fundam. Appl. Toxicol. 4, S224-S230 (1984).
25. Nolan, L.M.A., Corish, J., Corrigan, O.I., Fitzpatrick, D. Int. J. Pharm. 341, 114-124 (2007).
26. Netzlaff, F., Kaca, M., Bock, U., Haltner-Ukomadu, E., Meiers, P., Lehr, C.-M., Schaefer, U.F.: Eur. J. Pharm. Biopharm. 66, 127-134 (2007).
27. Rai, V., Ghosh, I., Bose, S., Silva, S.M.C., Chandra, P., Michniak-Kohn, B.: J. Drug Deliv. Sci. Tec. 20, 75-87 (2010).
28. Wagner, H., Kostka, K.-H., Lehr, C.-M., Schaefer, U.F.: J. Control. Release 75, 283-295 (2001).
29. Siewert, M., Dressman, J., Brown, C.K., Shah, V.P.: FIP/AAPS Guidelines to Dissolution/in Vitro Release Testing of Novel/Special Dosage Forms. AAPS Pharm. Sci. Tech. 4, 1-10 (2003).
30. Schroeder, I.Z., Franke, P., Schaefer, U.F., Lehr, C.-M.: J. Control. Release 118, 196-203 (2007).
31. Vaddi, H.K., Ho, P.C., Chan, Y.W., Chan, S.Y.: J. Control. Release 81, 121-133 (2002).
32. Bernard, G., Auger, M., Soucy, J., Pouliot, R.: Biochim. Biophys. Acta 1770, 1317-1323 (2007)
33. Boncheva, M., Damien, F., Normand, V.: Biochim. Biophys. Acta 1778, 1344-1355 (2008)
34. Dias, M., Naik, A., Guy, R.H., Hadgraft, J., Lane, M.E.: Eur. J. Pharm. Biopharm. 69, 1171-1175 (2008)
35. Bommannan, D., Potts, R.O., Guy, R.H.: J. Invest. Dermatol. 95, 403-408 (1990)
36. Brancaleon, L., Bamberg, M.P., Sakamaki, T., Kollias, N.: J. Invest. Dermatol. 116, 380-386 (2001)
37. Hahn, T., Hansen, S., Neumann, D., Kostka, K.-H., Lehr, C.-M., Muys, L., Schafer, U.F.:. Skin Pharmacol. Physiol. 23, 183-192 (2010)
38. Thiele, J.J., Traber, M.G., Packer, L.: J. Invest. Dermatol. 110, 756-761 (1998)
39. Gremlich, H.U., Yan, B.: New York: Marcel Dekker 42, (2001)
40. Csizmazia, E., Erocombining double acute accents, G., Berkesi, O., Berkó, Sz., Szabó-Révész, P., Csányi, E.: J. Drug Deliv. Sci. Tec. 21, 411-415 (2011)
41. Csizmazia, E., Erocombining double acute accents, G., Berkesi, O., Berkó, Sz., Szabó-Révész, P., Csányi, E.: Pharm. Dev. Technol. 17, 125-128 (2012)
42. Bolzinger, M.A., Thevenin, Carduner, C., Poelman, M.C.: Int. J. Pharm. 176, 39-45 (1998).
43. Ganem-Quintanar, A., Lafforgue, C., Falson-Rieg, F., Buri, P.: Int. J. Pharm. 147, 165-171 (1997).
44. Godwin, D.A., Kim, N.-H., Felton, L.A.: Eur. J. Pharm. Biopharm. 53, 2327 (2002).